CLASCOTERONE

CLASCOTERONE was reported 1419 times

CLASCOTERONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FORDYCE SPOTS 1 0.1429
1 PRODUCT PROCESS CONTROL ISSUE 1 0.0833
2 PRODUCT PHYSICAL CONSISTENCY ISSUE 329 0.0594
3 EYELID SCAR 1 0.0263
4 MALABSORPTION FROM APPLICATION SITE 4 0.0261
5 PURGING 2 0.0192
6 PRODUCT USE COMPLAINT 286 0.0181
7 PSEUDOFOLLICULITIS 1 0.0159
8 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 4 0.0111
9 PELVIC FLOOR DYSFUNCTION 2 0.0094
10 ORAL ALLERGY SYNDROME 1 0.0090
11 APPLICATION SITE ACNE 4 0.0082
12 POOR QUALITY PRODUCT ADMINISTERED 84 0.0080
13 DEVELOPMENTAL REGRESSION 1 0.0074
14 SIMPLE PARTIAL SEIZURES 5 0.0062
15 RENAL PAPILLARY NECROSIS 1 0.0047
16 PRODUCT PHYSICAL ISSUE 78 0.0039
17 PRODUCT STORAGE ERROR 333 0.0038
18 DERMAL ABSORPTION IMPAIRED 1 0.0036
19 ANDROGENETIC ALOPECIA 1 0.0035
20 LIQUID PRODUCT PHYSICAL ISSUE 25 0.0034
21 ACNE CYSTIC 10 0.0033
22 PRODUCT APPEARANCE CONFUSION 3 0.0032
23 PRODUCT DEPOSIT 5 0.0032
24 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
25 SKIN STRIAE 4 0.0027
26 CHEMICAL BURN 3 0.0026
27 ADMINISTRATION SITE REACTION 1 0.0026
28 ACNE PUSTULAR 2 0.0024
29 SPHINCTER OF ODDI DYSFUNCTION 1 0.0024
30 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
31 POST INFLAMMATORY PIGMENTATION CHANGE 1 0.0022
32 CHLOASMA 1 0.0022
33 HYPERMOBILITY SYNDROME 1 0.0020
34 THERAPY CESSATION 86 0.0017
35 PERIORAL DERMATITIS 1 0.0016
36 HYPOTRICHOSIS 1 0.0016
37 VULVAL DISORDER 1 0.0015
38 OPHTHALMIC MIGRAINE 1 0.0014
39 SEBORRHOEA 5 0.0014
40 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
41 PRESCRIPTION FORM TAMPERING 1 0.0013
42 DRUG TOLERANCE INCREASED 1 0.0013
43 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
44 PUSTULE 3 0.0013
45 THYROID HORMONES DECREASED 1 0.0013
46 SINUSITIS FUNGAL 1 0.0012
47 PROCEDURAL NAUSEA 1 0.0012
48 ADRENAL SUPPRESSION 1 0.0012
49 PRODUCT CONTAMINATION PHYSICAL 3 0.0012
50 SKIN WOUND 2 0.0012
51 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
52 TERMINAL INSOMNIA 2 0.0011
53 APPLICATION SITE DISCOMFORT 2 0.0011
54 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
55 SKIN TEXTURE ABNORMAL 1 0.0010
56 HAIR GROWTH ABNORMAL 7 0.0010
57 AUTONOMIC NEUROPATHY 1 0.0010
58 STEROID WITHDRAWAL SYNDROME 1 0.0010
59 THYROID HORMONES INCREASED 1 0.0010
60 APPLICATION SITE PAPULES 1 0.0009
61 SKIN EROSION 3 0.0009
62 APPLICATION SITE DRYNESS 3 0.0009
63 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
64 PRODUCT CONTAINER ISSUE 7 0.0008
65 PRODUCT USE ISSUE 153 0.0008
66 TRISOMY 21 1 0.0008
67 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
68 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
69 CORNEAL ABRASION 1 0.0007
70 DISCHARGE 1 0.0007
71 INTERMENSTRUAL BLEEDING 4 0.0007
72 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
73 APPLICATION SITE REACTION 5 0.0007
74 PRODUCT DISPENSING ISSUE 3 0.0007
75 EXPIRED PRODUCT ADMINISTERED 22 0.0007
76 AMENORRHOEA 11 0.0006
77 PRODUCT DOSE OMISSION ISSUE 184 0.0006
78 ACNE 46 0.0006
79 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
80 TREATMENT DELAYED 1 0.0006
81 SCRATCH 6 0.0006
82 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
83 HYPERTRICHOSIS 1 0.0005
84 PRODUCT LEAKAGE 3 0.0005
85 ATROPHY 1 0.0005
86 SKIN IRRITATION 23 0.0005
87 REBOUND ATOPIC DERMATITIS 1 0.0005
88 PRODUCT QUALITY ISSUE 67 0.0005
89 APPLICATION SITE EXFOLIATION 2 0.0005
90 PRODUCT LOT NUMBER ISSUE 1 0.0005
91 YELLOW SKIN 2 0.0004
92 PRODUCT PACKAGING ISSUE 4 0.0004
93 EOSINOPHIL COUNT DECREASED 1 0.0004
94 PAINFUL RESPIRATION 1 0.0004
95 HORMONE LEVEL ABNORMAL 2 0.0004
96 JUVENILE IDIOPATHIC ARTHRITIS 1 0.0004
97 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
98 DERMATOMYOSITIS 1 0.0004
99 MENOPAUSE 1 0.0004
100 BREAST SWELLING 1 0.0004
101 SKIN DISCOMFORT 1 0.0004
102 SKIN ATROPHY 2 0.0003
103 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
104 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
105 FACIAL PAIN 3 0.0003
106 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
107 PRODUCT DISPENSING ERROR 7 0.0003
108 PRODUCT FORMULATION ISSUE 2 0.0003
109 SKIN INJURY 1 0.0003
110 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
111 THERAPY INTERRUPTED 21 0.0003
112 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
113 MENSTRUATION DELAYED 3 0.0003
114 CHRONIC SINUSITIS 1 0.0003
115 SKIN BURNING SENSATION 19 0.0003
116 POLYDIPSIA 1 0.0003
117 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
118 CONDITION AGGRAVATED 76 0.0002
119 PRODUCT ADMINISTRATION ERROR 5 0.0002
120 PERIPHERAL VENOUS DISEASE 1 0.0002
121 TRIGGER FINGER 1 0.0002
122 ARTHRITIS BACTERIAL 1 0.0002
123 MENSTRUAL DISORDER 2 0.0002
124 HORDEOLUM 1 0.0002
125 VULVOVAGINAL DISCOMFORT 1 0.0002
126 IRON DEFICIENCY 1 0.0002
127 HEAVY MENSTRUAL BLEEDING 2 0.0002
128 SKIN ABRASION 1 0.0002
129 SUBCUTANEOUS ABSCESS 1 0.0002
130 FOOT OPERATION 1 0.0002
131 INABILITY TO AFFORD MEDICATION 2 0.0002
132 INITIAL INSOMNIA 2 0.0002
133 VENTRICULAR EXTRASYSTOLES 2 0.0002
134 TENDERNESS 2 0.0002
135 PRODUCT ODOUR ABNORMAL 2 0.0002
136 PARTIAL SEIZURES 1 0.0002
137 PRODUCT RESIDUE PRESENT 1 0.0002
138 SKIN LACERATION 2 0.0002
139 INTRACRANIAL PRESSURE INCREASED 1 0.0002
140 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
141 SCAR 3 0.0002
142 MICTURITION URGENCY 2 0.0002
143 PRODUCT PRESCRIBING ERROR 4 0.0002
144 CYST 2 0.0002
145 FOREIGN BODY SENSATION IN EYES 1 0.0002
146 SKIN EXFOLIATION 13 0.0002
147 SOMNAMBULISM 1 0.0002
148 BLOOD TESTOSTERONE DECREASED 1 0.0001
149 ERYTHEMA 30 0.0001
150 DERMATITIS 3 0.0001
151 SKIN REACTION 2 0.0001
152 PAPULE 1 0.0001
153 INTENTIONAL UNDERDOSE 1 0.0001
154 APPLICATION SITE PAIN 3 0.0001
155 SENSITIVE SKIN 1 0.0001
156 SUNBURN 1 0.0001
157 BREAST TENDERNESS 1 0.0001
158 POST PROCEDURAL INFECTION 1 0.0001
159 SKIN DISORDER 4 0.0001
160 SKIN HYPERPIGMENTATION 1 0.0001
161 PRODUCT COMMUNICATION ISSUE 1 0.0001
162 DRUG ERUPTION 2 0.0001
163 DRY SKIN 15 0.0001
164 MENSTRUATION IRREGULAR 3 0.0001
165 DRUG INEFFECTIVE 146 0.0001
166 LUPUS-LIKE SYNDROME 1 0.0001
167 HIDRADENITIS 1 0.0001
168 SKIN DISCOLOURATION 5 0.0001
169 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
170 PRODUCT DISTRIBUTION ISSUE 1 0.0001
171 MIDDLE INSOMNIA 2 0.0001
172 APPENDICITIS 1 0.0001
173 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
174 DISEASE RECURRENCE 5 0.0001
175 SLEEP APNOEA SYNDROME 2 0.0001
176 PHARYNGEAL SWELLING 1 0.0001
177 FOLLICULITIS 1 0.0001
178 BREAST PAIN 1 0.0001
179 PRODUCT PRESCRIBING ISSUE 2 0.0001
180 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
181 SKIN INFECTION 1 0.0001
182 REBOUND EFFECT 1 0.0001
183 PRODUCT AVAILABILITY ISSUE 2 0.0001
184 SURGERY 5 0.0001
185 WRIST FRACTURE 1 0.0001
186 THERAPEUTIC RESPONSE DECREASED 5 0.0001
187 ADRENAL INSUFFICIENCY 1 0.0001
188 APPLICATION SITE IRRITATION 1 0.0001
189 DERMATITIS ALLERGIC 1 0.0001
190 INTRAOCULAR PRESSURE INCREASED 1 0.0001
191 GASTRITIS 2 0.0001
192 QUALITY OF LIFE DECREASED 1 0.0001
193 ABNORMAL DREAMS 2 0.0001
194 SEASONAL ALLERGY 1 0.0001
195 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
196 INTENTIONAL DOSE OMISSION 2 0.0001
197 PARALYSIS 1 0.0001
198 PRODUCT SUBSTITUTION ISSUE 4 0.0001
199 URINARY INCONTINENCE 2 0.0001
200 SKIN HAEMORRHAGE 1 0.0001
201 RESPIRATORY DISORDER 2 0.0001
202 THYROID DISORDER 1 0.0001
203 GYNAECOMASTIA 2 0.0001
204 ABSCESS 1 0.0001
205 MUSCLE TIGHTNESS 1 0.0001
206 SWELLING FACE 4 0.0001
207 PHOTOSENSITIVITY REACTION 1 0.0001
208 FACE OEDEMA 1 0.0001
209 INFLAMMATION 3 0.0001
210 NIGHTMARE 2 0.0001
211 RASH 25 0.0001
212 DERMATITIS ATOPIC 3 0.0001
213 PRODUCT ADHESION ISSUE 2 0.0001
214 RASH PRURITIC 3 0.0001
215 PELVIC PAIN 1 0.0001
216 DYSURIA 2 0.0001
217 FEELING JITTERY 1 0.0001
218 INCREASED APPETITE 1 0.0001
219 EYE IRRITATION 3 0.0001
220 SKIN FISSURES 1 0.0001
221 PRURITUS 19 0.0000
222 FEEDING DISORDER 1 0.0000
223 EXPOSURE DURING PREGNANCY 3 0.0000
224 POOR QUALITY SLEEP 1 0.0000
225 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
226 ANGIOEDEMA 2 0.0000
227 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
228 PANCREATITIS ACUTE 1 0.0000
229 HEART RATE IRREGULAR 1 0.0000
230 OFF LABEL USE 38 0.0000
231 MUSCLE TWITCHING 1 0.0000
232 SEIZURE 5 0.0000
233 HYPERSENSITIVITY 8 0.0000
234 BURNING SENSATION 3 0.0000
235 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
236 PRODUCTIVE COUGH 2 0.0000
237 DRY EYE 2 0.0000
238 PRODUCT COMPLAINT 1 0.0000
239 RESPIRATORY TRACT INFECTION 1 0.0000
240 SEDATION 1 0.0000
241 THROAT TIGHTNESS 1 0.0000
242 MOOD ALTERED 1 0.0000
243 TREATMENT NONCOMPLIANCE 2 0.0000
244 SKIN LESION 1 0.0000
245 BLISTER 2 0.0000
246 LETHARGY 2 0.0000
247 DYSSTASIA 1 0.0000
248 DISEASE PROGRESSION 4 0.0000
249 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
250 INJECTION SITE RASH 1 0.0000
251 SWOLLEN TONGUE 1 0.0000
252 MIGRAINE 3 0.0000
253 STAPHYLOCOCCAL INFECTION 1 0.0000
254 INSOMNIA 8 0.0000
255 FUNGAL INFECTION 1 0.0000
256 URTICARIA 5 0.0000
257 HEART RATE DECREASED 1 0.0000
258 LYMPHADENOPATHY 1 0.0000
259 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
260 INJECTION SITE MASS 1 0.0000
261 DYSGEUSIA 2 0.0000
262 EYE SWELLING 1 0.0000
263 INJECTION SITE SWELLING 2 0.0000
264 EMOTIONAL DISTRESS 3 0.0000
265 EXTRA DOSE ADMINISTERED 1 0.0000
266 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
267 ANXIETY 7 0.0000
268 OSTEOPOROSIS 1 0.0000
269 WITHDRAWAL SYNDROME 1 0.0000
270 VAGINAL HAEMORRHAGE 1 0.0000
271 MENTAL DISORDER 1 0.0000
272 INTENTIONAL PRODUCT MISUSE 2 0.0000
273 THERAPY NON-RESPONDER 1 0.0000
274 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
275 SUICIDAL IDEATION 2 0.0000
276 FATIGUE 17 0.0000
277 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
278 PAIN 13 0.0000
279 OCULAR HYPERAEMIA 1 0.0000
280 DYSPHAGIA 2 0.0000
281 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
282 ATRIAL FIBRILLATION 2 0.0000
283 ALOPECIA 4 0.0000
284 HEART RATE INCREASED 2 0.0000
285 SINUSITIS 2 0.0000
286 HAEMORRHAGE 2 0.0000
287 ECZEMA 1 0.0000
288 DISTURBANCE IN ATTENTION 1 0.0000
289 MEDICATION ERROR 1 0.0000
290 INFLUENZA 2 0.0000
291 EYE PAIN 1 0.0000
292 RHEUMATOID ARTHRITIS 2 0.0000
293 DEPRESSION 4 0.0000
294 IRRITABILITY 1 0.0000
295 DISCOMFORT 1 0.0000
296 NASOPHARYNGITIS 3 0.0000
297 VISUAL IMPAIRMENT 2 0.0000
298 INFUSION RELATED REACTION 1 0.0000
299 BLOOD PRESSURE DECREASED 1 0.0000
300 VISION BLURRED 2 0.0000
301 SLEEP DISORDER 1 0.0000
302 DIZZINESS 7 0.0000
303 MALAISE 6 0.0000
304 UNEVALUABLE EVENT 1 0.0000
305 INCORRECT DOSE ADMINISTERED 3 0.0000
306 BLOOD PRESSURE INCREASED 2 0.0000
307 PERIPHERAL SWELLING 2 0.0000
308 DECREASED APPETITE 3 0.0000
309 DRUG INTERACTION 2 0.0000
310 DRY MOUTH 1 0.0000
311 INFLUENZA LIKE ILLNESS 1 0.0000
312 TREATMENT FAILURE 1 0.0000
313 MYALGIA 2 0.0000
314 BALANCE DISORDER 1 0.0000
315 COVID-19 2 0.0000
316 GASTROINTESTINAL DISORDER 1 0.0000
317 ADVERSE DRUG REACTION 1 0.0000
318 MUSCLE SPASMS 2 0.0000
319 OROPHARYNGEAL PAIN 1 0.0000
320 WEIGHT DECREASED 3 0.0000
321 BREAST CANCER 1 0.0000
322 COUGH 3 0.0000
323 SWELLING 1 0.0000
324 DYSPNOEA 6 0.0000
325 NAUSEA 8 0.0000
326 SOMNOLENCE 2 0.0000
327 CHEST DISCOMFORT 1 0.0000
328 ILLNESS 1 0.0000
329 ABDOMINAL DISTENSION 1 0.0000
330 HEADACHE 6 0.0000
331 CONSTIPATION 2 0.0000
332 WEIGHT INCREASED 2 0.0000
333 MUSCULAR WEAKNESS 1 0.0000
334 PYREXIA 3 0.0000
335 PALPITATIONS 1 0.0000
336 OEDEMA PERIPHERAL 1 0.0000
337 ASTHENIA 3 0.0000
338 LOSS OF CONSCIOUSNESS 1 0.0000
339 HYPERHIDROSIS 1 0.0000
340 PSORIASIS 1 0.0000
341 ARTHRALGIA 3 0.0000
342 INFECTION 1 0.0000
343 PAIN IN EXTREMITY 2 0.0000
344 VOMITING 3 0.0000
345 PNEUMONIA 2 0.0000
346 URINARY TRACT INFECTION 1 0.0000
347 CHEST PAIN 1 0.0000
348 ABDOMINAL PAIN UPPER 1 0.0000
349 HYPERTENSION 1 0.0000
350 BACK PAIN 1 0.0000
351 ABDOMINAL PAIN 1 0.0000
352 FEELING ABNORMAL 1 0.0000
353 INJECTION SITE PAIN 1 0.0000
354 DIARRHOEA 2 0.0000
355 FALL 1 0.0000